Epidarex Capital: Will This Fund Be the Poster Child for Early Stage Investment?
In EpidarexOctober, 2014 – Epidarex is a specialist life science venture capital group that recently raised a new fund of £47.5 million dedicated to UK start ups and university spin outs. Backers include US drug giant Eli Lilly, the Universities of Edinburgh, Glasgow and Aberdeen, King’s…